- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Mar 31, 2025 | 658.05M sh |
| Short Term Debt | Q2 2025 · Mar 31, 2025 | $1.26B |
| Short Term Debt | Q2 2025 · Sep 30, 2024 | $953M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $15.81B |
| Stockholders Equity | Q2 2025 · Sep 30, 2024 | $16.1B |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $11.82B |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $11.96B |
| Current Assets | Q2 2025 · Mar 31, 2025 | $11.35B |
| Current Assets | Q2 2025 · Sep 30, 2024 | $11.18B |
| Total Assets | Q2 2025 · Mar 31, 2025 | $42.37B |
| Total Assets | Q2 2025 · Sep 30, 2024 | $42.7B |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $606M |
| Cash And Equivalents restated | Q2 2025 · Mar 31, 2024 | $838M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 679M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 681.5M sh |
| Stock Repurchased | Q2 2025 · Mar 31, 2024 | $474M |
| Dividends Paid | Q2 2025 · Mar 31, 2024 | $504M |
| Capex restated | Q2 2025 · Mar 31, 2024 | $210M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.41 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.14 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.41 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.14 |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $2.06B |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $3.4B |
| Net Income | Q2 2025 · Mar 31, 2024 | −$277M |
| Net Income | Q2 2025 · Mar 31, 2024 | $97M |
| Gross Profit restated | Q2 2025 · Mar 31, 2024 | $1.92B |
| Gross Profit restated | Q2 2025 · Mar 31, 2024 | $3.7B |
| Cost Of Revenue restated | Q2 2025 · Mar 31, 2024 | $3.68B |
| Cost Of Revenue restated | Q2 2025 · Mar 31, 2024 | $7.11B |
| Revenue restated | Q2 2025 · Mar 31, 2024 | $5.6B |
| Revenue restated | Q2 2025 · Mar 31, 2024 | $10.81B |